Quick Answer
QuidelOrtho Corp reported Net Income Loss of -$1.13 billion for the year ending 2025.
- QuidelOrtho Corp showed an increase of +44.8% in Net Income Loss from 2024 to 2025.
- This data is from QuidelOrtho Corp's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $178.10 million | Q2 2021: $19.10 million | Q3 2021: $215.70 million | Q1 2022: $479.90 million | Q2 2022: $19.30 million | Q3 2022: $19.20 million | Q1 2023: $48.80 million | Q2 2023: -$53.20 million | Q3 2023: -$12.70 million | Q1 2024: -$1.71 billion | Q2 2024: -$147.70 million | Q3 2024: -$19.90 million | Q1 2025: -$12.70 million | Q2 2025: -$255.40 million | Q3 2025: -$733.00 million.
- Over the full 6 years of available data (2020 to 2025), QuidelOrtho Corp's Net Income Loss has declined by 239.7%.
- Historical annual values: Fiscal year 2025: -$1.13 billion | Fiscal year 2024: -$2.05 billion | Fiscal year 2023: -$10.10 million | Fiscal year 2022: $548.70 million | Fiscal year 2021: $704.20 million | Fiscal year 2020: $810.30 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: